Observational study / 2019
Circulating but not fecal short-chain fatty acids were linked to insulin sensitivity, lipolysis, and GLP-1 concentrations in humans.
In a cross-sectional study of 160 participants, researchers examined associations of fecal and fasting circulating short-chain fatty acids (SCFA) with metabolic markers, including insulin sensitivity measured via hyperinsulinemic-euglycemic clamp in a subgroup of 93. Fasting circulating acetate, propionate, and butyrate were positively associated with fasting GLP-1. Circulating SCFA were negatively associated with whole-body lipolysis (glycerol: std β adj -0.190, P = 0.023), triacylglycerols (std β adj -0.202, P = 0.010), and free fatty acids (std β adj -0.306, P = 0.001). Circulating acetate was negatively correlated with insulin sensitivity (M-value: std β adj -0.294, P < 0.001), whereas propionate was positively correlated (std β adj 0.161, P = 0.033).
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional study
- Who was studied
- 160 participants (64% male, BMI 19.2-41.0 kg/m2, normal or impaired glucose metabolism)
- What was measured
- Circulating metabolites, substrate oxidation, GLP-1 concentrations, and insulin sensitivity
THE PAPER
Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans.
Müller M, Hernández MAG, Goossens GH, Reijnders D, Holst JJ, Jocken JWE, van Eijk H, Canfora EE, Blaak EE. Sci Rep, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.